异动解读|Dianthus Therapeutics盘中上涨9.22%,报104.14美元

行情直击
Jul 18

7月18日,Dianthus Therapeutics盘中上涨9.22%,报104.14美元/股,成交额7534.37万美元。

Dianthus Therapeutics所在的生物科技行业中,个股中,艾伯维公司涨0.57%,安进跌2.31%,吉利德科学跌1.37%,福泰制药跌0.37%,再生元制药公司跌0.67%。

Dianthus Therapeutics是一家临床阶段的生物技术公司,致力于设计和提供新型单克隆抗体,与现有的补体疗法相比,其选择性和效力更高。公司正在开发产品组合以便单独使用或相互结合使用,旨在成为移植医学领域完全整合的发现、开发和商业公司。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10